Related Articles
LY294002 suppresses the malignant phenotype and sensitizes osteosarcoma cells to pirarubicin chemotherapy
Overexpression of the prolyl isomerase PIN1 promotes cell growth in osteosarcoma cells
Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell lines
Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells
Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma